Founded in 2009, Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of the drug discovery process. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotech and academic groups.
We collaborate with Optibrium on an Innovate UK grant funded project to harness the power of AI to learn from complex data and guide scientists in the design and testing of potential new drugs.
You can find out more about Optibrium on their website.
